Related references
Note: Only part of the references are listed.The Signaling Pathway of the ADP Receptor P2Y12 in the Immune System: Recent Discoveries and New Challenges
Philomena Entsie et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Protective Effect of Ticagrelor Against Infective Endocarditis Induced by Virulent Staphylococcus aureus in Mice
Cécile Oury et al.
JACC-Basic to Translational Science (2023)
Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention: a GLOBAL LEADERS substudy
Barry W. Hennigan et al.
PLATELETS (2022)
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19 A Randomized Clinical Trial
Jeffrey S. Berger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
Diana A. Gorog et al.
NATURE REVIEWS CARDIOLOGY (2022)
Platelets as Key Factors in Inflammation: Focus on CD40L/CD40
Fabrice Cognasse et al.
FRONTIERS IN IMMUNOLOGY (2022)
Impact of Clopidogrel on Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: a National Retrospective Cohort Study
Aisling R. Caffrey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
P2Y12-dependent activation of hematopoietic stem and progenitor cells promotes emergency hematopoiesis after myocardial infarction
Hana Seung et al.
BASIC RESEARCH IN CARDIOLOGY (2022)
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial
Charlotte A. Bradbury et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy
Thomas A. Nelson et al.
PLATELETS (2022)
Platelet Extracellular Vesicles: Beyond the Blood
Florian Puhm et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment
Aleksandra Gasecka et al.
CARDIOVASCULAR DRUGS AND THERAPY (2021)
Role of platelets and megakaryocytes in adaptive immunity
Genevieve Marcoux et al.
PLATELETS (2021)
Cangrelor in addition to standard therapy reduces cardiac damage and inflammatory markers in patients with ST-segment elevation myocardial infarction
Mohamed Abo-Aly et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
P2Y12 Inhibition in Murine Myocarditis Results in Reduced Platelet Infiltration and Preserved Ejection Fraction
Sarah Nasreen Schmidt et al.
CELLS (2021)
Aspirin or Ticagrelor in Staphylococcus aureus Infective Endocarditis: Where Do We Stand?
Kirsten Leeten et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Adenosine Diphosphate Improves Wound Healing in Diabetic Mice Through P2Y12 Receptor Activation
Paula Alvarenga Borges et al.
FRONTIERS IN IMMUNOLOGY (2021)
Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment
Michela Giustozzi et al.
BLOOD REVIEWS (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Transporters
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Ticagrelor added to methotrexate improves rheumatoid arthritis disease severity
Michael S. Garshick et al.
RHEUMATOLOGY (2021)
Antithrombotic therapy for patients with chronic coronary syndromes
William A. E. Parker et al.
HEART (2021)
Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study
Taiki Masuyama et al.
HEART AND VESSELS (2021)
Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
Romy Hansildaar et al.
LANCET RHEUMATOLOGY (2021)
Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels
William A. E. Parker et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Pharmacology and potential role of selatogrel, a subcutaneous platelet P2Y(12) receptor antagonist
William A. E. Parker et al.
EXPERT OPINION ON EMERGING DRUGS (2020)
P2Y12 Inhibition beyond Thrombosis: Effects on Inflammation
Alexandre Mansour et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel
Aleksandra Gasecka et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: effects on platelet function and cellular adenosine uptake
Kok Weng Ow et al.
PLATELETS (2020)
Role of Platelet-Derived Growth Factor (PDGF) in Asthma as an Immunoregulatory Factor Mediating Airway Remodeling and Possible Pharmacological Target
Grzegorz Kardas et al.
FRONTIERS IN PHARMACOLOGY (2020)
Platelets trigger perivascular mast cell degranulation to cause inflammatory responses and tissue injury
Jorn Karhausen et al.
SCIENCE ADVANCES (2020)
Role of platelet biomarkers in inflammatory response
Yufei Chen et al.
BIOMARKER RESEARCH (2020)
Effect of Ticagrelor on Reducing the Risk of Gram-Positive Infections in Patients With Acute Coronary Syndrome
Lior Lupu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Prevention of stroke in patients with chronic coronary syndromes or peripheral arterial disease
William A. E. Parker et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2020)
3D ultrastructural analysis of α-granule, dense granule, mitochondria, and canalicular system arrangement in resting human platelets
Irina D. Pokrovskaya et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Beyond a neurotransmitter: The role of serotonin in inflammation and immunity
Hera Wu et al.
PHARMACOLOGICAL RESEARCH (2019)
Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria
Patrizio Lancellotti et al.
JAMA CARDIOLOGY (2019)
Sepsis: Inflammation Is a Necessary Evil
Christina Nedeva et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Platelet-Dense Granules Worsen Pre-Infection Thrombocytopenia during Gram-Negative Pneumonia-Derived Sepsis
Theodora A. M. Claushuis et al.
JOURNAL OF INNATE IMMUNITY (2019)
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Chronic inflammation in the etiology of disease across the life span
David Furman et al.
NATURE MEDICINE (2019)
Platelet factor 4-containing immune complexes induce platelet activation followed by calpain-dependent platelet death
Tatiana A. Nevzorova et al.
CELL DEATH DISCOVERY (2019)
P2Y12 receptor modulation of ADP-evoked intracellular Ca2+ signalling in THP-1 human monocytic cells
J. J. Micklewright et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease
Rachel C. Orme et al.
CIRCULATION (2018)
Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia
Travis R. Sexton et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
An exploratory look at NETosis in atherosclerosis
Chiara Mozzini et al.
INTERNAL AND EMERGENCY MEDICINE (2017)
Effect of ticagrelor on the serum level of hs-CRP, ESM-1 and short-term prognosis of patients with acute STEMI
Peng Wei et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study
William A. Parker et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor
Riyaad Aungraheeta et al.
BLOOD (2016)
Ticagrelor: agonising over its mechanisms of action
William A. E. Parker et al.
BLOOD (2016)
Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54
William A. E. Parker et al.
HEART (2016)
The immune system's role in sepsis progression, resolution, and long-term outcome
Matthew J. Delano et al.
IMMUNOLOGICAL REVIEWS (2016)
Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
S. Claiborne Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel
Shokoufeh Hajsadeghi et al.
CLINICAL MEDICINE INSIGHTS-CARDIOLOGY (2016)
Involvement of P2Y12 receptor in vascular smooth muscle inflammatory changes via MCP-1 upregulation and monocyte adhesion
Hiroshi Satonaka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
P-selectin promotes neutrophil extracellular trap formation in mice
Julia Etulain et al.
BLOOD (2015)
Platelet secretory behaviour: as diverse as the granules ... or not?
H. Heijnen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Effect of P2Y12 inhibitors on inflammation and immunity
Mark R. Thomas et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Microvesicles from platelets: novel drivers of vascular inflammation
Tanja Vajen et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis
Khalaf F. Alsharif et al.
VASCULAR PHARMACOLOGY (2015)
Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus
Tiago Rafael Veloso et al.
PATHOGENS AND DISEASE (2015)
Effect of prasugrel in patients with asthma: results of PRINA, a randomized, double-blind, placebo-controlled, cross-over study
F. Lussana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Vessel wall, not platelet, P2Y12 potentiates early atherogenesis
Laura E. West et al.
CARDIOVASCULAR RESEARCH (2014)
Dual-Contrast Molecular Imaging Allows Noninvasive Characterization of Myocardial Ischemia/Reperfusion Injury After Coronary Vessel Occlusion in Mice by Magnetic Resonance Imaging
Dominik von Elverfeldt et al.
CIRCULATION (2014)
Human Endotoxin Administration as an Experimental Model in Drug Development
A. F. Suffredini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion
Chaker Aloui et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1
Duncan Armstrong et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2014)
Characterization of the platelet granule proteome: Evidence of the presence of MHC1 in alpha-granules
Anne Zufferey et al.
JOURNAL OF PROTEOMICS (2014)
Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Agonist-bound structure of the human P2Y12 receptor
Jin Zhang et al.
NATURE (2014)
Ticagrelor reduces neutrophil recruitment and lung damage in abdominal sepsis
Milladur Rahman et al.
PLATELETS (2014)
Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism
S. Nylander et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness
A. Kendall Gross et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock
Gordon Philipp Otto et al.
PLATELETS (2013)
Prasugrel Metabolites Inhibit Neutrophil Functions
Elisabetta Liverani et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
The Inflammatory Chemokine CXC Motif Ligand 16 Triggers Platelet Activation and Adhesion Via CXC Motif Receptor 6-Dependent Phosphatidylinositide 3-Kinase/Akt Signaling
Oliver Borst et al.
CIRCULATION RESEARCH (2012)
Effects of prasugrel on platelet inhibition during systemic endotoxaemia: a randomized controlled trial
Alexander O. Spiel et al.
CLINICAL SCIENCE (2012)
P2Y12 receptors in platelets and other hematopoietic and non-hematopoietic cells
Christian Gachet
PURINERGIC SIGNALLING (2012)
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
Edwin van der Pol et al.
PHARMACOLOGICAL REVIEWS (2012)
Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis
Elisabeth M. Battinelli et al.
BLOOD (2011)
Platelet receptor signaling in thrombus formation
David Stegner et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
The P2X1 receptor and platelet function
Martyn P. Mahaut-Smith et al.
PURINERGIC SIGNALLING (2011)
ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST CLOPIDOGREL SULFATE ATTENUATES LPS-INDUCED SYSTEMIC INFLAMMATION IN A RAT MODEL
Satoshi Hagiwara et al.
SHOCK (2011)
Adenosine Diphosphate Receptor P2Y12-Mediated Migration of Host Smooth Muscle-Like Cells and Leukocytes in the Development of Transplant Arteriosclerosis
Kosuke Harada et al.
TRANSPLANTATION (2011)
Changes in Inflammatory Biomarkers in Patients Treated With Ticagrelor or Clopidogrel
Steen Husted et al.
CLINICAL CARDIOLOGY (2010)
Antiplatelet drugs and outcome in mixed admissions to an intensive care unit
Johannes Winning et al.
CRITICAL CARE MEDICINE (2010)
Platelet α-granules: Basic biology and clinical correlates
Price Blair et al.
BLOOD REVIEWS (2009)
The platelet as an immune cell-CD40 ligand and transfusion immunomodulation
Neil Blumberg et al.
IMMUNOLOGIC RESEARCH (2009)
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Raul Elgueta et al.
IMMUNOLOGICAL REVIEWS (2009)
Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor
Sailaja Paruchuri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Anti-platelet drugs and outcome in severe infection: Clinical impact and underlying mechanisms
Johannes Winning et al.
PLATELETS (2009)
Pharmacokinetics and Pharmacodynamics of Prasugrel, a Thienopyridine P2Y12 Inhibitor
Paul P. Dobesh
PHARMACOTHERAPY (2009)
Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling
Jeff S. Isenberg et al.
BLOOD (2008)
Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions
Goran Rudez et al.
HUMAN MUTATION (2008)
The active metabolite of prasugrel effectively blocks the platelet P2Y(12) receptor and inhibits procoagulant and pro-inflammatory platelet responses
Heather M. Judge et al.
PLATELETS (2008)
Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease
Oscar O. Braun et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin
Andrew L. Frelinger et al.
THROMBOSIS AND HAEMOSTASIS (2007)
From hematopoietic stem cells to platelets
Y. Chang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation
Joshua A. Boyce
IMMUNOLOGICAL REVIEWS (2007)
A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans
Joseph A. Jakubowski et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting - Results from the CLEAR PLATELETS 1b study
Paul A. Gurbel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease
Svein Solheim et al.
THROMBOSIS AND HAEMOSTASIS (2006)
Continuous signaling via PI3K isoforms β and γ is required for platelet ADP receptor function in dynamic thrombus stabilization
Judith M. E. M. Cosemans et al.
BLOOD (2006)
Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease -: Evidence for antioxidant and antiinflammatory effects
Thomas Heitzer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of β1 and B2 integrins
Paula A. da Costa Martins et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease -: art. no. e1
RR Azar et al.
AMERICAN HEART JOURNAL (2006)
Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome
YG Chen et al.
CHINESE MEDICAL JOURNAL (2006)
Biology and pharmacology of the platelet P2Y(12) receptor
Robert F. Storey
CURRENT PHARMACEUTICAL DESIGN (2006)
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
ZM Chen et al.
LANCET (2005)
Early endotoxin-mediated haemostatic and inflammatory responses in the clopidogrel-treated pig
M Lipcsey et al.
PLATELETS (2005)
Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway
M Schnurr et al.
BLOOD (2005)
Role of P-selectin and PSGL-I in coagulation and thrombosis
ER Vandendries et al.
THROMBOSIS AND HAEMOSTASIS (2004)
Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention
DP Vivekananthan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Bidirectional relation between inflammation and coagulation
M Levi et al.
CIRCULATION (2004)
A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the ADET trial
M Woodward et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome
ZH Xiao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, αMβ2)
M Schwarz et al.
THROMBOSIS RESEARCH (2002)
ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999
FL Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Identification of the platelet ADP receptor targeted by antithrombotic drugs
G Hollopeter et al.
NATURE (2001)
The central role of the P-2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity
RF Storey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
